Reviewing inclusivity of the UK bladder and head and neck oncology trial portfolio through eligibility criteria: a scoping review
This review highlights common exclusion criteria which may disproportionately exclude underserved groups from UK bladder and head and neck oncology trials. To facilitate accessibility to oncology trials, sponsors and triallists should consider how potentially underrepresented groups may be safely included during development of eligibility criteria.
Authors
- Judith M. Bliss (ORCID: https://orcid.org/0000-0001-7957-7424)
- H. Gribble
- Ka Wang Cheung (ORCID: https://orcid.org/0000-0003-1207-6494)
- Lucy Kilburn (ORCID: https://orcid.org/0000-0002-1987-7545)
- Morgaine Stiles (ORCID: https://orcid.org/0009-0004-5509-913X)
- Karen Poole (ORCID: https://orcid.org/0000-0002-6172-5297)
- Rebecca Lewis (ORCID: https://orcid.org/0000-0001-9222-5263)
- Georgiana Synesi
- Emma Hall
Institutions
- Institute of Cancer Research (GB)
- Cancer Research UK (GB)
- Cancer Research UK Clinical Trials Unit (GB)
Publication Details
- Journal
- Trials
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1186/s13063-026-09424-w
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00